ABX-1431 hydrochloride is primarily used in research and development within the pharmaceutical industry, particularly in the study of neurological disorders. It functions as a potent and selective inhibitor of the enzyme monoacylglycerol lipase (MAGL), which plays a significant role in the regulation of endocannabinoid signaling. By inhibiting MAGL, ABX-1431 hydrochloride helps modulate the levels of 2-arachidonoylglycerol (2-AG), a key endocannabinoid, leading to potential therapeutic effects in conditions such as anxiety, pain, and neurodegenerative diseases. Its application is crucial in preclinical studies aimed at understanding the endocannabinoid system and developing novel treatments for disorders influenced by this pathway. Additionally, it is explored for its potential anti-inflammatory and neuroprotective properties, making it a valuable tool in neuroscience research.